BRELASPEN

Trademark usage description

pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders, diseases and disorders of the central nervous system Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders and spinal cord diseases, cancer, pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries, osteoporosis; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; analgesics and anti-infectives

Classification kind code

Mark Details

Serial Number

1825708

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 14 on 21^st Sept 2020	Default Notice Sent
Submitted for opposition 50 on 1^st Jun 2018	Allowed
Submitted for opposition 51 on 1^st Jun 2018	Allowance Notice Sent
Submitted for opposition 42 on 14^th Feb 2018	Advertised
Submitted for opposition 26 on 25^th Jan 2018	Approved
Submitted for opposition 22 on 4^th Dec 2017	Search Recorded
Submitted for opposition 27 on 4^th Dec 2017	Approval Notice Sent
Submitted for opposition 31 on 8^th Mar 2017	Formalized
Submitted for opposition 1 on 6^th Mar 2017	Created
Submitted for opposition 30 on 3^rd Mar 2017	Filed